Navigation Links
RT Oncology Services Signs Distribution Agreement with Metro Medical Supply, Inc.
Date:1/5/2012

SAN DIEGO, Jan. 5, 2012 /PRNewswire/ -- RT Oncology Services Corp. (RainTree Oncology), a privately-held provider of oral oncology drug acquisition and management services, announced it has signed a distribution agreement with Metro Medical Supply, Inc., a leading privately-held wholesale distributor of prescription and over-the-counter pharmaceuticals. The agreement marks the establishment of RainTree Oncology's national distribution network and enables the Company to provide crucial oral drug services to community oncology practices nationwide.

"Metro Medical Supply, Inc.'s collective expertise in distribution and service will allow us to provide our practice members with fast, reliable and cost-effective access to oral oncology medications," said Mike Martin, president and chief executive officer of RainTree Oncology.  "This agreement is an important step toward helping community oncology practices improve their operations and efficiencies, which will ultimately benefit their patients."

"We are pleased to partner with RainTree Oncology, which has created an innovative model for providing services and oral medications to community oncologists," said Michael Cooper, president of Metro Medical Supply, Inc. "We look forward to assisting with the distribution of high quality products at competitive prices, which will benefit community oncologists and the care of their patients."

RainTree Oncology recently announced the launch of services aimed at strengthening community oncology practice by: 1) forming a community oncology network allied with RainTree Oncology through which members can obtain oral pharmaceuticals at favorably contracted prices; 2) helping to implement on-site pharmacies for those practices that do not have one, providing added convenience and improved care for patients, and an important source of revenue for physicians; and 3) providing practice pharmacists with unique automated tools that improve tracking of oral drug prescriptions and fulfillment to promote higher levels of patient adherence to prescribed therapeutics.

In the United States, community oncologists provide care for the majority of cancer patients. Increasingly, changes in healthcare economics are impacting how these practices operate, putting pressure on their ability to deliver essential services to their patients. Oral drug acquisition and management can be particularly problematic as the drugs are expensive and often not fully reimbursed. The distribution agreement between Metro Medical Supply, Inc. and RainTree Oncology will help alleviate the cost burden that this places on practices and their patients.

About RainTree Oncology Services

RainTree Oncology Services provides leading-edge oral drug acquisition and management services that make a difference in the lives of cancer patients by helping community oncology practices expand services and improve patient care, enhancing the economic model of community oncology practices and pioneering an integrated information network between physicians, payors and manufacturers to advance state of the art in oral oncology. RainTree Oncology is physician centric, patient focused and community minded. For more information about RainTree Oncology Services visit www.raintreeoncology.com.


'/>"/>
SOURCE RainTree Oncology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Pa. , Oct. 12, 2017 ... leader in innovative solutions for injectable drug administration, today ... before the market opens on Thursday, October 26, 2017, ... the results and business expectations at 9:00 a.m. Eastern ... (U.S.) or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):